Grazoprevir potassium salt
Product Specifications
CAS Number
1206524-86-8
Target
HCV Protease|||Others|||SARS-CoV
Related Pathways
Microbiology/Virology|||Others|||Proteases/Proteasome
Bioactivity
Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets.
Smiles
N(C(=O)[C@H]1N2C[C@@](C1)(OC=3C(=NC=4C(N3)=CC(OC)=CC4)CCCCC[C@]5([C@](OC(=O)N[C@@H]([C@@](C)(C)C)C2=O)(C5)[H])[H])[H])[C@@]6(C(NS(=O)(=O)C7CC7)=O)[C@H](C=C)C6.[K]
Molecular Formula
C38H49KN6O9S
Molecular Weight
805
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/AFE46E26-5093-4D9D-9CBC-F7FDA7361D38/T19948
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15146781 1 Vial
Lentiviral human C11orf49 shRNA (UAS) - Lentiviral human C11orf49 shRNA (UAS, GFP) (100)
Ask
View Details 